LIPIDS ABNORMAL side effect
What is LIPIDS ABNORMAL ?LIPIDS ABNORMAL : Vytorin Side Effects Report #5643055-9
Physician from UNITED STATES reported VYTORIN problem on Feb 18, 2008. Female patient was diagnosed with hypercholesterolaemia and was treated with VYTORIN. After drug was administered, patient experienced the following problems/side effects: lipids abnormal, pancreatitis, . VYTORIN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PREMARIN. Patient was hospitalized. Patient recovered.
LIPIDS ABNORMAL : Cellcept Side Effects Report #5391416-8
CELLCEPT problem was reported by a Pharmacist from UNITED KINGDOM on July 10, 2007. Female patient, 70 years of age, weighting 121.3 lb, was diagnosed with demyelinating polyneuropathy and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: lipids abnormal, . CELLCEPT dosage: unknown. During the same period patient was treated with CANDESARTAN, WARFARIN, IMMUNE GLOBULIN INTRAVENOUS, BISOPROLOL, SPIRONOLACTONE, FUROSEMIDE INTENSOL, ISOSORBIDE MONONITRATE. Patient recovered.
LIPIDS ABNORMAL : Cellcept Side Effects Report #5391416-8
Pharmacist from UNITED KINGDOM reported CELLCEPT problem on July 10, 2007. Female patient, 70 years of age, weighting 121.3 lb, was diagnosed with demyelinating polyneuropathy and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: lipids abnormal, . CELLCEPT dosage: unknown. During the same period patient was treated with CANDESARTAN, WARFARIN, IMMUNE GLOBULIN INTRAVENOUS, BISOPROLOL, SPIRONOLACTONE, FUROSEMIDE INTENSOL, ISOSORBIDE MONONITRATE. Patient recovered.
LIPIDS ABNORMAL : Cymbalta Side Effects Report #5678762-5
CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2008. Male patient, 36 years of age, weighting 181.0 lb, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: high density lipoprotein increased, lipids abnormal, . CYMBALTA dosage: unknown. During the same period patient was treated with SONATA. Patient recovered.
LIPIDS ABNORMAL : Aranesp Side Effects Report #5612097-1
Physician from FRANCE reported ARANESP problem on Jan 21, 2008. Female patient, weighting 142.2 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: conjunctival haemorrhage, lipids abnormal, pain, . ARANESP dosage: unknown. During the same period patient was treated with AVANDIA, NOVONORM, TRIATEC, EURELIX, ASPEGIC, CLONAZEPAM. Patient recovered.
LIPIDS ABNORMAL : Tekturna Side Effects Report #5634047-4
TEKTURNA problem was reported by a Physician from UNITED STATES on Nov 20, 2007. Female patient was treated with TEKTURNA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme abnormal, lipids abnormal, . TEKTURNA dosage: unknown. During the same period patient was treated with BETA BLOCKING AGENTS. Patient recovered.
LIPIDS ABNORMAL : Claravis Side Effects Report #5400892-3
Physician from UNITED STATES reported CLARAVIS problem on July 17, 2007. Male patient, 71 years of age, weighting 170.0 lb, was diagnosed with rosacea and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: chest pain, coronary arterial stent insertion, lipids abnormal, . CLARAVIS dosage: 20 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
LIPIDS ABNORMAL : Phenytoin Side Effects Report #5401618-X
PHENYTOIN problem was reported by a Consumer or non-health professional from CANADA on Feb 12, 2007. Male patient, 61 years of age, was diagnosed with epilepsy, hypercholesterolaemia and was treated with PHENYTOIN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, lipids abnormal, . PHENYTOIN dosage: DAILY DOSE:500MG-FREQ:DAILY. During the same period patient was treated with ATORVASTATIN CALCIUM, NIACIN, EZETIMIBE, ASPIRIN, FOSINOPRIL, PHENOBARBITAL. Patient recovered.
LIPIDS ABNORMAL : Claravis Side Effects Report #5400892-3
Physician from UNITED STATES reported CLARAVIS problem on July 17, 2007. Male patient, 71 years of age, weighting 170.0 lb, was diagnosed with rosacea and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: chest pain, coronary arterial stent insertion, lipids abnormal, . CLARAVIS dosage: 20 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
LIPIDS ABNORMAL : Phenytoin Side Effects Report #5401618-X
PHENYTOIN problem was reported by a Consumer or non-health professional from CANADA on Feb 12, 2007. Male patient, 61 years of age, was diagnosed with epilepsy, hypercholesterolaemia and was treated with PHENYTOIN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, lipids abnormal, . PHENYTOIN dosage: DAILY DOSE:500MG-FREQ:DAILY. During the same period patient was treated with ATORVASTATIN CALCIUM, NIACIN, EZETIMIBE, ASPIRIN, FOSINOPRIL, PHENOBARBITAL. Patient recovered.